Talking of CEOs, there is a new one at antibody discoverer Visterra.
Dr. Brian Pereira will replace Steven Brugger in the role of CEO and President, as well as taking a place on the Board. He previously served as President and CEO of AMAG Pharmaceuticals between 2006 and 2011, and before that he was President and CEO of a Tufts Medical Center Physician Organization.
“Brian brings his proven industry leadership with an impressive track record for managing high-performance teams and building significant company value, and these skills will augment the expertise of the existing Visterra team to advance the company’s strategy and product development programs,” said Alan Crane, Visterra’s Chairman.
The latest changes at Bayer, biopharma, and the winner of Professional Woman of the Year in this...
This week's pharmaceutical changes begin with the election of Reuters' head to the Board of Pfizer.
Big changes in biologics in this week's column, as we round up the pharma industry's new scientific...
Plus the small companies which have hired senior scientists from Bristol-Myers Squibb and Merck Serono.
Plus senior pharma hires in the US and Asia in this week's column.